Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES Plunges 5%; BSE HEALTHCARE Index Down 0.4%
Wed, 25 Sep 14:58

GLENMARK LIFE SCIENCES Plunges 5%; BSE HEALTHCARE Index Down 0.4%Image source: KanawatTH/www.istockphoto.com

GLENMARK LIFE SCIENCES share price has plunged 5% and is presently trading at Rs 1,052.8.

Meanwhile, the BSE HEALTHCARE index is at 44,038.0 (down 0.4%).

Among the top losers in the BSE HEALTHCARE index today are ASTRAZENECA PHARMA (down 4.3%) and MAX HEALTHCARE INSTITUTE (down 4.2%).

ALKEM LABORATORIES (up 3.4%) and NARAYANA HRUDAYALAYA (up 2.2%) are among the top gainers today.

Over the last one year, GLENMARK LIFE SCIENCES has moved up from Rs 629.5 to Rs 1,052.8, registering a gain of Rs 423.3 (up 67.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,800.9 to 44,038.0, registering a gain of 58.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 183.9%), SUVEN PHARMACEUTICALS (up 126.5%) and Glenmark Pharma (up 114.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 84,951.9 .

The top gainers among the BSE Sensex today are Power Grid Corp. (up 3.8%) and Axis Bank (up 1.8%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 25,936.8 . LTIMINDTREE and Tech Mahindra are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.7 to 84,951.9, registering a gain of 18,928.2 points (up 28.7%).

GLENMARK LIFE SCIENCES Financial Update...

GLENMARK LIFE SCIENCES net profit fell 17.7% YoY to Rs 1,115 million for the quarter ended June 2024, compared to a profit of Rs 1,355 million a year ago. Net sales rose 1.8% to Rs 5,886 million during the period as against Rs 5,785 million in April-June 2023.

For the year ended March 2024, GLENMARK LIFE SCIENCES reported 0.8% increase in net profit to Rs 4,709 million compared to net profit of Rs 4,670 million during FY23. Revenue of the company grew 5.6% to Rs 22,832 million during FY24.

The current Price to earnings ratio of GLENMARK LIFE SCIENCES, based on rolling 12 month earnings, stands at 28.9.


Equitymaster requests your view! Post a comment on "GLENMARK LIFE SCIENCES Plunges 5%; BSE HEALTHCARE Index Down 0.4%". Click here!